Chongqing Zhixia Chemical Co., Ltd. (Nanjing Chenruisheng Group)

Chongqing Zhixia Chemical Co., Ltd. (related to Nanjing Chenruisheng Biomedical Technology) was established in September 2023. It is a small and micro enterprise, mainly engaged in the research and development and supply of polypeptide GLP-1 raw materials, representing products including Semaglutide, Tirzepatide and other polypeptide raw materials. The business model is factory, customization and service, and the products are mostly marked as "for scientific research or export only". The company announced a registered capital of 500,000 yuan, 10–50 employees, and an annual turnover of about 3-5 million yuan. The contact information is shared with Nanjing Chen Ruisheng (the same phone/email address), and is positioned as a peptide small molecule GLP-1 raw material supplier for the global scientific research and export market.

Chongqing Zhixia Chemical Co., Ltd. (Nanjing Chenruisheng Group) is located at Nanjingshishuangyunyingzhongxin, Chongqing, China.

Main peptides produced: Epitalon, MOTS-c, Semax, DSIP.

Finished peptide dosage forms available (lyophilised powder for injection).